Иванова когда у ребенка астма скачать

1. Global Strategy for Asthma Management and prevention. Reviset 2014; 84–103: https://www.ginasthma.org

2. Savenije O.E., Kerkhof M., Koppelman G.H. et al. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012; 130: 325–331.

3. Pescatore A.M., Dogaru C.M., Duembgen L. et al. A simple asthma prediction tool for preschool children with wheeze or cough. J Allergy Clin Immunol 2014; 133: 111–118.

4. Brand P.L.P., Baraldi E., Bisgaard H. et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096–1110.

5. Bush A., Griggpro J., Saglani S. Managing wheeze in preschool children. BMJ 2014; 348: 1–7.

6. Cane R.S., Ranganathan S.C., McKenzie S.A. What do parents of wheezy children understand by «wheeze»? Arch Dis Child 2000; 82: 327–332.

7. Желенина Л.А., Акимова С.Л., Галустян А.Н., Пшенич- ная К.И. Острая и хроническая обструктивная патология у детей. ЦМТ СПбГПМУ, 2015; 34. (Zhelenina L.A., Akimova S.L., Galustyan A.N., Pshenichnaya K.I. Acute and chronic obstructive pathology at children. St. Petersdurg, 2015; 34. (in Russ))

8. Papadopoulos N.G., Kalobatsou A. Respiratory viruses in childhood asthma. Curr Opin Allergy Clin Immunol 2007; 7: 91–95.

9. Pocket Guide for Asthma Management and Prevention (for Children 5 Years and Yonger), a Guide for Health Care Professiоnals, 2015; www.ginasthma.jrg

10. Savenije O.E., Granell R., Caudri D. et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol 2011; 127: 6: 1505–1512.

11. Schultz A., Devadason S.G., Savenije O.E. et al. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010; 99:56–60.

12. Kappelle L., Brand P.L. Severe episodic viral wheeze in preschool children: High risk of asthma at age 5–10 years. Eur J Pediatr 2012; 171: 947–954.

13. Бугримо Д. Ю., Анохина В.В., Муравицкая М.Н. Особенности течения острых респираторных вирусных заболеваний у детей с фенотипическими признаками недифференцированной дисплазии соединительной ткани. Вестн новых мед технол 2011; 18: 2: 225–226. (Bugrimo D.Yu., Anokhina V.V., Muravitskaya M.N. Features of a current of acute respiratory viral diseases at children with phenotypical symptoms of an undifferentiated dysplasia of connecting fabric. Vestn novykh med tekhnol 2011; 18: 2: 225–226. (in Russ))

14. Woodcock A., Lowe L.A., Murray C.S. et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 2004; 170: 4: 433–439.

15. Hofhuis W., van der Wiel E.C., Tiddens H. et al. Bronchodilation in infants with malacia or recurrent wheeze. Arch Dis Child 2003; 88: 246–249.

16. Browne G.J., Penna A.S., Phung X., Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997; 349: 301–305.

17. Bisgaard H., Hermansen M.N., Loland L. et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998–2005.

18. Murray C.S., Woodcock A., Langley S.J. et al. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368: 754–762.

19. Doull I.J. M., Lampe F.C., Smith S. et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997; 315: 858–862.

20. Brand P.L., Caudri D., Eber E. et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43: 1172–1177.

21. Kaditis A.G., Winnie G., Syrogiannopoulos G.A. Antiinflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol 2007; 42: 407–420.

22. Guilbert T.W., Morgan W.J., Zeiger R.S. et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985–1997.

23. de Blic J., Delacourt C., Le Bourgeois M. et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996; 98: 14–20.

24. Belgrave D.C., Buchan I., Bishop C. et al. Trajectories of lung function during childhood. Am J Respir Crit Care Med 2014; 189: 1101–1109.

25. Herr M., Clsrisse B., Nikasinovic L. et al. Das allergic rhinitis exist in infancy? Fandings from the PARIS birth cohort.J Allergy Euro J Allergy Clin Immunol 2011; 66: 2: 214–221.

26. Педиатрия. Национальное руководство в 2 т. М.: ГЭОТАР-Медиа, 2009; 2: 24–34. (Pediatrics. A national management. Moscow: GEOTAR-media, 2009; 2: 24–34. (in Russ))

27. Иванова Н.А., Терентьева Ж.Н., Ченоусова Е.А. Возможности улучшения диагностики аллергического ринита у детей дошкольного возраста. CONSILIUM MEDICUM Педиатрия 2014; 1: 31–34. (Ivanova N.A., Terentyeva Zh.N., Chenousova E.A. Possibilities of improvement of diagnosis of allergic rhinitis at children of preschool age. CONSILIUM MEDICUM Pediatriya 2014; 1: 31–34. (in Russ))

28. Ducharme F.M., Sharon S.D., Radhakrishman D. et al. Diagnosis and management of asthma in preschools: A Canadian Thoracic Society position paper. Can Respir J 2015; 22: 3:135–144.

29. Castro-Rodriguez J.A., Rodrigo G.J. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch Dis Child 2010; 95: 5: 365–370.

30. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». 4-е изд., пераб. и доп. Москва: Оригинал-макет, 2012; 122. (The national program «Bronchial asthma at children. Strategy of treatment and prophylaxis». 4th edition. Moscow: Original-maket, 2012; 122. (in Russ))

31. Архипов В.В. Прозорова В.К., Архипова Д. Е. и др. Сравнительная эффективность ингаляционных ГКС. Эффективная фармакотерапия 2013; 21: 32–39. (Arkhipov V.V., Prozorova V.K., Arkhipova D.E. et al. Comparative efficiency of inhalation GKS. EHffektivnaya farmakoterapiya of 2013; 21: 32–39. (in Russ))

32. Camargo C.A. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 2007; 64: 10: 1054–1061.

33. Chen A.H., Zeng G.Q., Chen R.C. et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology 2013; 18: Suppl 3: 47–52.

34. Matthews E.E. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma Acta Paediatr 1999; 88: 8: 841–843.

35. Derendorf H., Nave R., Drollmann A. et al. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Eur Respir J 2006; 28: 5: 1042–1050.

36. Kelly H.W. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids. Ann Allergy Asthma Immunol 2003; 91: 4: 326–334.

37. Miller-Larsson A. Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification. Am J Respir Crit Care Med 2000; 162: 4: Pt 1: 1455–1461.

38. Инструкция по медицинскому применению препарата Пульмикорт суспензия для ингаляций дозированная, 0,25 мг/мл, 0,5 мг/мл ПN 13826/01 от 20.10.2011 с учетом изменений 1,2 от 02.03.2015; www.medi.ru/doc/0919. htm. (The instruction for medical application of Pulmikort suspension for inhalations 0,25 mg/ml, 0,5 mg/ml 13826/01 of 20.10.2011 taking into account changes 1,2 of 02.03.2015; www.medi.ru/doc/0919.htm. (in Russ))

39. Agertoft L. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 15: 1064–1069.

40. Kemp J.P. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol 1999; 83: 3: 231–239.